e-resolutions

Resolutions voted on electronically by members of the Unitaid Executive Board

2018

December

R20-2018-e
Unitaid support to WHO prequalification of medicines and in vitro diagnostics, and to the WHO collaborative procedure for registration (2019-2021)

R19-2018-e
Go-ahead for the development of grant agreement packages on better tools for integrated management of childhood fever for proposed projects with PATH and ALIMA

R18-2018-e
Go-ahead for the development of grant agreement packages on preventing deaths from cervical cancer for proposed projects with Clinton Health Access Initiative (CHAI) and Expertise France

R17-2018-e
Additional Contribution from the United Kingdom

R16-2018-e
Terms of Reference of the Unitaid 2017-2021 Midterm Strategy Review

October

R15-2018-e
Go ahead for the development of grant agreement packages for proposed projects with Koninklijke Nederlandse Centrale Vereniging tot bestrijding der Tuberculose (KNCV), FIND, Celltrion, Inc. and Stellenbosch University for the treatment of tuberculosis and its drug-resistant strains

September

R14-2018-e
Expand New Drug Markets for TB (endTB) Project

August

R13-2018-e
Go ahead for the development of an agreement with EJAF to co-finance a Demand Creation Campaign and Challenge Fund for HIVST

R12-2018-e
Catalytic Long Lasting Insecticidal Nets (LLIN) Initiative

R11-2018-e
Expanding the use of TRIPS flexibilities to promote affordable access to medicines

R10-2018-e
Use of TRIPS flexibilities to increase affordability of treatment for HIV, tuberculosis and hepatitis C virus in middle-income countries

July

R9-2018-e
Calendar of Board and Committee meetings 2019

R8-2018-e
Appointment of Interim Board Chair

R7-2018-e
Health for all: Increasing access to HIV, TB and Hepatitis C treatment through effective use of TRIPS flexibilities

R6-2018-e
Go-ahead for the development of a grant agreement package for the extension and expansion of the Expand New Drug Markets for TB Project

R5-2018-e
ATLAS – Autotest, libre d’accéder à la connaissance de son statut VIH

April

R4-2018-e
Accelerating Demand for HIV Self-Testing (HIVST) Among Young People

March

R3-2018-e
Go ahead for the development of grant agreement package with the Innovative Vector Control Consortium (lVCC) under the Area for Intervention “Accelerating the adoption of innovative vector control tools”

February

R2-2018-e
Calendar of Board and Committee meetings 2018

January

R1-2018-e
Go ahead for the development of grant agreement packages on new tools for vector control for proposed projects with Barcelona Institute for Global Health (ISGlobal), University of Notre Dame and Wageningen University

2017

December

R23-2017-e
Costed Extension of the HIV /HCV Drug Affordability project

R22-2017-e
Go ahead for the development of the International Treatment Preparedness Coalition (lTPC), South Centre (SC) and Third World Network (TWN) grant packages under the Area for Intervention “Supporting the use of TRIPS flexibilities”

R21-2017-e
Integrating PrEP into Comprehensive Services for Adolescent Girls and Young Women in South Africa

October

R20-2017-e
Catalyzing pediatric TB innovation (CAP TB)

R19-2017-e
WHO TB Enabler Grant

R18-2017-e
Increase to budget ceilings for the RAS and TIPTOP Projects

R17-2017-e
WHO-HTM Enabler malaria sub-grant

August

R16-2017-e
Indemnification of WHO with respect to claims under a Bank of England Mandate Letter

R15-2017-e
Strengthening paediatric TB services for enhanced early detection (TB SPEED)

R14-2017-e
IMPAACT4TB Increasing market and public health outcomes through scaling up affordable access models of short course preventive therapy for TB

R13-2017-e
Amended Calendar of Board and Committee meetings dates for the fourth quarter of 2017

R12-2017-e
No cost extension of the Project “Market entry of an improved solid protease inhibitor-based first line antiretroviral combination therapy for infants and young children with HIV/AIDS” by DNDi

R11-2017-e
Costed extension of the ACCESS-SMC project

July

R10-2017-e
Go ahead for the development of Solthis and MTV Staying Alive Foundation (SAF) proposals on HIV self-testing

R9-2017-e
Amendment to Workstream 2 (PrEP and HIV Self-Testing) of the WHO HTM Enabler HIV/HCV sub-grant

R8-2017-e
Self-Testing AfRica (STAR) Initiative

R7-2017-e
Preparedness for the rollout of effective HIV prevention among Key affected Populations in Brazil, Peru and Mexico

R6-2017-e
Costed extension of Unitaid project support to WHO Prequalification of Medicines and Diagnostics

R5-2017-e
Malaria Vaccine Pilot Implementation Programme

April

R4-2017-e
Medicines for Malaria Venture Supply Side Grant

R3-2017-e
No cost extension of MSF Project “Implementation of CD4 and Viral Load Testing in Decentralised, Remote and Resource-Limited Settings

R2-2017-e
TIPTOP – Transforming IPT for Optimal Pregnancy

R1-2017-e
Rectal Artesunate – RAS Project

2016

December

R18-2016-e
Go-ahead for the Aurum “IMPAACT4TB” proposal

November

R17-2016-e
Go-ahead for the development of paediatric TB project proposals

R16-2016-e
Safer, more robust and less expensive antiretroviral first-line therapy (ADVANCE trial)

R15-2016-e
A randomised trial to compare dolutegravir+darunavir/r versu recommended standard of care antiretroviral regimens in patients with HIV infection who have failed recommended first-line therapy

R14-2016-e
DolPHIN2: Dolutegravir in Pregnant HIV mothers and Neonates

September

R13-2016-e
Accelerating access and integration of innovative point-of-care HIV technologies in national diagnostic programs – Phase 2b

R12-2016-e
E-market place for the procurement of public health commodities (wambo.org)

R10-2016-e
P3: Private Sector Provision of PrEP Sep 2016

August

R9-2016-e
Enabling Scale-up of PrEP and Linkage to Testing among sexually active older adolescents with substantial HIV risk

R8-2016-e
Unlocking the Hepatitis C Diagnostics and Treatment Market Sep 2016

R7-2016-e
WHO HTM Enabler sub-grant HIV/HCV

R6-2016-e
Accelerating Patient Access to Optimal Antiretrovirals

June

R4-2016-e
Go-ahead for the development of project proposals

R3-2016-e
Enabling access to first-line antiretroviral treatment in low-income countries

R2-2016-e
Go-ahead for the development of project proposaI for the “E-marketpIace”

R1-2016-e
Market intervention to accelerate uptake of new vector control tools

R1-2015-e
Calendar of Unitaid Board meetings for 2015

2015

November

R2-2015-e
Calendar of Unitaid board meetings for 2015

June

R3-2015-e
Go-ahead for the development of project proposaIs

2014

June

R3-2014-e
Stimulating and shaping the market for HIV self-testing in Africa: two-tier demonstration and evaluation of accuracy and linkage in 4 countries

R2-2014-e
Unitaid revised project budget 2014

January

R1-2014-e
Unitaid Key Performance Indicators 2013-2016

2013

July

R6-2013-e
Endorsement of Unitaid KPI Report 2012

R5-2013-e
Endorsement of Unitaid Strategy 2013-2016

June

R4-2013-e
MDR-TB Strategic Rotating Stockpile Project_No-cost extension

R3-2013-e
MDR-TB Scale-up Initiative Project_No-cost Extension

R1- 2013-e
Additional Funding for AMFm Transition Year 2013

Sign Up for Unitaid Updates

  • This field is for validation purposes and should be left unchanged.